Proton magnetic resonance spectroscopy and biochemical investigation of type 2 diabetes mellitus in Asian Indians: observation of high muscle lipids and C-reactive protein levels

Magnetic Resonance Imaging

Volumn 27, Issue 1, 2009, Pages 94-100

  Sinha, Sanjeev ^a   Misra, Anoop ^a   Rathi, Manish ^a   Kumar, Virendra ^a   Pandey, Ravindra M ^a   Luthra, Kalpana ^a   Jagannathan, Naranamangalam R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

C reactive protein (CRP); Insulin resistance; Intramyocellular lipids (IMCLs); Magnetic resonance spectroscopy (MRS); Type 2 diabetes mellitus (T2DM)

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL OBESITY; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; INSULIN RESISTANCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INDIA; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; LIPID METABOLISM; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MUSCLE, SKELETAL; PROTONS; STATISTICS, NONPARAMETRIC;

EID: 57049163562     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2008.06.001     Document Type: Article

References (43)

1. Bahceci M., Tuzcu A., Ogun C., Canoruc N., Iltimur K., and Aslan C. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?. J Endocrinol Invest 28 (2005) 145-150
2. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 (2000) 836-843
3. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D.S., and Haffneret S.M. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
4. Chambers J.C., Eda S., Bassett P., Karim Y., Thompson S.G., Gallimore J.R., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European Whites. Circulation 104 (2001) 145-150
5. Forouhi N.G., Sattar N., and McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 25 (2001) 1327-1331
6. Cook D.G., Mendall M.A., Whincup P.H., Carey I.M., Ballam L., Morris J.E., et al. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis 149 (2000) 139-150
7. Vikram N.K., Misra A., Dwivedi M., Sharma R., Pandey R.M., Luthra K., et al. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 168 (2003) 305-313
8. Pradhan A.D., Cook N.R., Buring J.E., Manson J.E., and Ridker P.M. C-reactive protein is independently associated with fasting insulin in nondiabetic women. Arterioscler Thromb Vasc Biol 23 (2003) 650-655
9. Morohoshi M., Fujisawa K., Uchimura I., and Numano F. Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. Diabetes 45 (1996) 954-959
10. Guha M., Bai W., Nadler J.L., and Natarajan R. Molecular mechanisms of tumor necrosis factor alpha gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways. J Biol Chem 275 (2000) 17728-17739
11. Ford E.S. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 22 (1999) 1971-1977
12. Hak A.E., Stehouwer C.D., Bots M.L., Polderman K.H., Schalkwijk C.G., Westendorp I.C., et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 19 (1999) 1986-1991
13. Festa A., D'Agostino Jr. R., Howard G., Mykkänen L., Tracy R.P., and Haffner S.M. Chronic sub-clinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 102 (2000) 42-47
14. Wu T., Dorn J.P., Donahue R.P., Sempos C.T., and Trevisan M. Associations of serum C-reactive protein with fasting insulin, glucose, and glycosylated hemoglobin: the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 155 (2002) 65-71
15. Aronson D., Bartha P., Zinder O., Kerner A., Shitman E., Markiewicz W., et al. Association between fasting glucose and C-reactive protein in middle-aged subjects. Diabet Med 21 (2004) 39-44
16. Schick F., Eismann B., and Jung W.I. Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo, two lipid compartments in muscle tissue. Magn Reson Med 29 (1993) 158-167
17. Rico-Sanz J., Moosavi M., Thomas E.L., McCarthy J., Coutts G.A., Saeed N., et al. In vivo evaluation of the effects of continuous exercise on skeletal muscle triglycerides in trained humans. Lipids 35 (2000) 1313-1318
18. 1H-MRS study. Magn Reson Med 45 (2001) 179-183
19. 1H NMR spectroscopy study. Diabetologia 42 (1999) 113-116
20. 31P NMR studies on the mechanism of insulin resistance in obesity. Diabetes 47 (1998) 381-386
21. 13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes 48 (1999) 1600-1606
22. Jacob S., Machann J., Rett K., Brechtel K., Volk A., Renn W., et al. Association of increased intramyocellular lipid content with insulin resistance in lean non-diabetic offspring of type 2 diabetic subjects. Diabetes 48 (1999) 1113-1119
23. Dudeja V., Misra A., Pandey R.M., Devina G., Kumar G., and Vikram N.K. Body mass index does not accurately predict overweight in Asian Indians in Northern India. Br J Nutr 86 (2001) 105-112
24. Misra A., Pandey R.M., Rama J., Sharma R., Vikram N.K., and Khanna N. High prevalence of obesity, dyslipidemia, and diabetes in urban slum population in Northern India. Int J Obes Relat Metab Disord 25 (2001) 1722-1729
25. McKeigue P.M., Shah B., and Marmot M.G. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337 (1991) 382-386
26. World Health Organization (WHO). Diabetes mellitus. Report of a WHO Study Group. Geneva: World Health Organization (1985) [WHO Technical Report Series, No 727]
27. Sinha S., Rathi M., Misra A., Kumar V., Kumar M., Jagannathan N.R., et al. Sub-clinical inflammation and soleus muscle intra-myocellular lipids in healthy Asian Indian males. Clin Endocrinol 63 (2005) 350-355
28. Kuriyan R., Petracchi C., Ferro-Luzzi A., Shetty P.S., and Kurpad A.V. Validation of expedient methods for measuring body composition in Indian adults. Ind J Med Res 107 (1998) 37-45
29. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP), Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
30. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
31. Misra A., Sinha S., Kumar M., Jagannathan N.R., and Pandey R.M. Proton magnetic resonance spectroscopy study of soleus muscle in non-obese healthy and type 2 diabetic Asian Northern Indian males: high intramyocellular lipid content correlates with excess body fat and abdominal obesity. Diabet Med 20 (2003) 361-367
32. World Health Organization. The Asia-Pacific Perspective. Redefining obesity and its treatment. International Diabetes Institute. Health Communications Australia Pty Ltd 2000. Available at. http://www.obesityasiapacific.com/default.htm [accessed July, 2006]
33. Hortobagyi T., Israel R.G., and O'Brien K.F. Sensitivity and specificity of Quetelet index to assess obesity in men and women. Eur J Clin Nutr 48 (1994) 369-375
34. Willett W.C., Dietz W.H., and Colditz G.A. Guidelines for healthy weight. N Engl J Med 341 (1999) 427-434
35. 1H-MR spectroscopy study. Int J Sports Med 27 (2006) 100-104
36. Petersen K.F., Dufour S., Feng J., Befroy D., Dziura J., Man C.D., Cobelli C., and Shulman G.I. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men. Proc Natl Acad Sci 103 (2006) 182773-182777
37. Falholt K., Jensen I., Lindkaer J.S., Mortensen H., Volund A., Heding L.G., et al. Carbohydrate and lipid metabolism of skeletal muscle in type 2 diabetic patients. Diab Med 5 (1988) 27-31
38. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
39. Freeman D.J., Norrie J., Caslake M.J., Gaw A., Ford I., Lowe G.D., et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes 51 (2002) 1596-1600
40. Forouhi N.G., Jenkinson G., Thomas E.L., Mullick S., Mierisova S., Bhonsle U., McKeigue P.M., and Bell J.D. Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men. Diabetologia 42 (1999) 932-935
41. Vikram N.K., Misra A., Pandey R.M., Dwivedi M., and Luthra K. Adiponectin levels in post-pubertal Asian Indian adolescents: relationships with insulin resistance and C-reactive protein. Metabolism 53 (2004) 1336-1341
42. Vikram N.K., Misra A., Pandey R.M., Dwivedi M., Luthra K., Dhingra V., and Talwar K.K. Association between sub-clinical inflammation and fasting insulin in urban young adult north Indian males. Ind J Med Res 124 (2006) 677-682
43. Tan K.C., Chow W.S., Tam S.C., Ai V.H., Lam C.H., and Lam K.S. Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab 87 (2002) 563-568